Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 35 Lymphoma 18 Urinary Bladder Neoplasms 10 Neoplasms 3 Melanoma 3 Leukemia 2 HIV Infections 2 Glioma 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urothelial Carcinoma of the Bladder 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Survival Without Progression 1 Skin Neoplasms 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pathologic Complete Response 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Mesothelioma, Malignant 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Kidney Neoplasms 1 Desmoid Tumors 1

Interventions

Temozolomide 37 Radiotherapy 20 Bevacizumab 14 Carboplatin 10 Magnetic Resonance Spectroscopy 9 Carmustine 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Irinotecan 8 Filgrastim 7 Cyclophosphamide 6 Cisplatin 6 Etoposide 5 sargramostim 4 Vincristine 4 Thiotepa 4 Surgical Procedures, Operative 4 Specimen Handling 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Lomustine 4 Everolimus 4 Chemotherapy, Adjuvant 4 trametinib 3 aldesleukin 3 Topotecan 3 Thalidomide 3 Tamoxifen 3 Sunitinib 3 Procarbazine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Astrocytoma × Vinblastine × Clear all

NCT05180825 2025-08-08

PLGG - MEKTRIC

University Hospital, Strasbourg, France

Phase 2 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡